BetterLife Pharma Inc.
BETR
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.28M | -2.56M | -3.01M | -3.59M | -3.31M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -749.60K | 583.20K | 1.40M | 1.52M | 1.47M |
| Change in Net Operating Assets | 1.17M | 497.80K | -43.40K | 227.20K | 372.70K |
| Cash from Operations | -858.90K | -1.48M | -1.66M | -1.84M | -1.46M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 1.22M | 1.52M | 1.52M | 1.52M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 773.10K | 748.10K | 739.40K | 1.13M | 707.40K |
| Repurchase of Common Stock | -- | -- | -100.00K | -100.00K | -100.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 20.20K | 20.20K | 20.20K | 20.20K |
| Cash from Financing | 563.80K | 1.46M | 1.61M | 1.89M | 1.59M |
| Foreign Exchange rate Adjustments | 0.00 | 0.00 | -100.00 | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -295.20K | -18.70K | -52.20K | 49.90K | 126.70K |